WealthCollab’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5K Sell
40
-51
-56% -$18.9K 0.01% 474
2026
Q1
$26.6K Buy
91
+27
+42% +$8.87K 0.01% 310
2025
Q4
$22.4K Sell
64
-10
-14% -$3.38K 0.01% 365
2025
Q3
$23.9K Sell
74
-43
-37% -$13.4K 0.01% 321
2025
Q2
$45.5K Sell
117
-12
-9% -$4.83K 0.03% 191
2025
Q1
$56.1K Buy
129
+99
+330% +$39.7K 0.03% 151
2024
Q4
$11.1K Buy
30
+9
+43% +$3.77K 0.01% 421
2024
Q3
$10.9K Buy
21
+7
+50% +$3.74K 0.01% 441
2024
Q2
$7.59K Hold
14
0.01% 484
2024
Q1
$7.26K Hold
14
0.01% 501
2023
Q4
$6.6K Buy
+14
New +$6.47K 0.01% 504

Other funds holding ELV

WealthCollab's ELV Position: Q2 2026 in Review

WealthCollab reduced its Elevance Health (ELV) stake by 56% in Q2 2026, selling an estimated $18.9K and leaving 40 shares worth $15.5K. The position accounts for 0.01% of the portfolio, ranked #474.

WealthCollab first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $56.1K in Q1 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • WealthCollab held 40 shares of Elevance Health worth $15.5K as of Q2 2026.
  • WealthCollab sold 51 Elevance Health shares in Q2 2026, an estimated $18.9K.
  • Elevance Health made up 0.01% of WealthCollab's portfolio in Q2 2026, its #474 holding.
  • WealthCollab first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Elevance Health position peaked at $56.1K in Q1 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.